Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer

MLA

Chaping Cheng, et al. “Gremlin1 Is a Therapeutically Targetable FGFR1 Ligand That Regulates Lineage Plasticity and Castration Resistance in Prostate Cancer.” Nature Cancer, vol. 3, May 2022, pp. 565–80. EBSCOhost, https://doi.org/10.1038/s43018-022-00380-3.

APA

Chaping Cheng, Jinming Wang, Penghui Xu, Kai Zhang, Zhixiang Xin, Huifang Zhao, Zhongzhong Ji, Man Zhang, Deng Wang, Yuman He, Na Jing, Liancheng Fan, Kaiyuan Liu, Fei Li, Chengcheng Liu, Yiming Gong, Suli Cui, Zhe Sun, Di Sun, … Helen He Zhu. (2022). Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer. Nature Cancer, 3, 565–580. https://doi.org/10.1038/s43018-022-00380-3

Chicago

Chaping Cheng, Jinming Wang, Penghui Xu, Kai Zhang, Zhixiang Xin, Huifang Zhao, Zhongzhong Ji, et al. 2022. “Gremlin1 Is a Therapeutically Targetable FGFR1 Ligand That Regulates Lineage Plasticity and Castration Resistance in Prostate Cancer.” Nature Cancer 3 (May): 565–80. doi:10.1038/s43018-022-00380-3.